AMYLOID CARDIOMYOPATHY
Clinical trials for AMYLOID CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new AMYLOID CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for AMYLOID CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common diabetes pill ease rare heart condition?
Disease control CompletedThis study tested the drug dapagliflozin (a diabetes medicine) in 50 adults with heart failure due to amyloid cardiomyopathy, a rare condition where abnormal proteins stiffen the heart. Researchers measured changes in quality of life, walking ability, and heart stress levels over…
Matched conditions: AMYLOID CARDIOMYOPATHY
Phase: NA • Sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation • Aim: Disease control
Last updated May 11, 2026 20:37 UTC
-
Protein clues may predict onset of rare genetic disease
Knowledge-focused CompletedThis study followed 37 people who carry a genetic mutation for hereditary ATTR amyloidosis but do not yet have symptoms. Over five years, researchers measured a specific misfolded protein in the blood to see if it changes when the disease starts or when treatment is needed. The g…
Matched conditions: AMYLOID CARDIOMYOPATHY
Sponsor: The Cleveland Clinic • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC
-
Could a lifetime of exercise protect your heart from a rare disease?
Knowledge-focused CompletedThis study looked at whether being physically active over a lifetime is linked to developing a rare heart condition called wild-type transthyretin amyloid cardiomyopathy. Researchers compared exercise histories of 180 people over age 60—some with the condition, some with heart fa…
Matched conditions: AMYLOID CARDIOMYOPATHY
Sponsor: Medical University of Graz • Aim: Knowledge-focused
Last updated May 07, 2026 18:40 UTC